ArticleJournal of translational medicine2014

Dual effects of a targeted small-molecule inhibitor (cabozantinib) on immune-mediated killing of tumor cells and immune tumor microenvironment permissiveness when combined with a cancer vaccine.

Anna R Kwilas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.